Abstract / Description of output
Eight patients with intractable cutaneous leucocytoclastic vasculitis were given a trial of plasma-exchange therapy. All but one improved, five substantially. Four have been successfully treated by intermittent plasma exchange for periods of 5-12 years. Apart from one episode of hepatitis B, possibly related to administration of fresh frozen plasma, no major adverse effects have occurred. Plasma exchange can be a valuable therapeutic option in patients with severe refractory cutaneous vasculitis.
Original language | English |
---|---|
Pages (from-to) | 411-5 |
Number of pages | 5 |
Journal | British journal of dermatology |
Volume | 122 |
Issue number | 3 |
Publication status | Published - Mar 1990 |
Keywords / Materials (for Non-textual outputs)
- Adult
- Aged
- Female
- Humans
- Male
- Middle Aged
- Plasma Exchange
- Skin Diseases
- Time Factors
- Vasculitis